Date: Wednesday, October 1
Time: 11:00AM-12:15PM (ET) including Q&A
As policy changes reshape the future of science and innovation, the biopharma industry is under unprecedented scrutiny. From drug pricing reforms and regulatory overhauls to evolving government funding priorities, policy turbulence is driving the narratives shaping public trust, investor confidence, and industry reputation. This session of The Briefing Room brings together leading journalists and policy analysts to examine how organizations can successfully navigate and reframe conversations about innovation and stay true to mission in a continuously changing policy environment.